Mississippi Governor Vetoes Medical Cannabis Expansion, Signs Psychedelic Research Bill

Mississippi's medical cannabis patients and advocates were dealt a major setback last week when Governor Tate Reeves rejected two bipartisan bills that would have significantly expanded the state's medical marijuana program. In a move that has sparked rallies at the state capitol, Reeves vetoed both House Bill 1152 and House Bill 895 — yet simultaneously signed separate legislation supporting research into psychedelic therapies for veterans. The contradictory decisions have left patients, lawmakers, and industry stakeholders demanding answers and pushing for an unprecedented veto override.

Key Takeaways

• Governor Tate Reeves vetoed two bipartisan medical cannabis expansion bills (HB 1152 and HB 895) that passed with veto-proof majorities in both chambers
• Both bills aimed to expand patient access, remove potency caps, and reduce administrative burdens on patients and caregivers
• Reeves simultaneously signed psychedelic research legislation, creating a policy contradiction that has energized cannabis advocates

Table of Contents

• What the Vetoed Bills Would Have Changed
• The Governor's Reasoning
• Veto-Proof Majorities and the Push for Override
• The Psychedelic Paradox
• What Comes Next for Mississippi Patients

What the Vetoed Bills Would Have Changed

The two medical cannabis expansion bills represented the most significant proposed reforms to Mississippi's medical marijuana program since voters approved Initiative 65 and the legislature subsequently passed the Mississippi Medical Cannabis Act.

House Bill 1152, known as the Right to Try Medical Cannabis Act, would have created an entirely new pathway for seriously ill patients to access cannabis-based treatments. Under the bill, patients suffering from severe conditions not currently on Mississippi's list of approved qualifying conditions could have worked directly with their treating physicians to access the program. The legislation was designed as a compassionate-access measure for individuals who had exhausted all other treatment options — a last resort for Mississippians facing terminal or debilitating illnesses.

House Bill 895 tackled several regulatory restrictions that patients and providers had long criticized as unnecessarily burdensome. The bill would have removed the current 60 percent THC potency cap on tinctures, oils, and concentrates — a limit that medical professionals argued prevented effective dosing for patients with severe symptoms. It also would have eliminated the mandate requiring patients to schedule follow-up visits with their recommending physicians every six months, and would have extended medical cannabis caregiver registrations from one year to two years, reducing administrative hurdles for families caring for disabled patients.

The Governor's Reasoning

In his veto message, Governor Reeves focused primarily on a provision in HB 1152 that would have made out-of-state residents eligible for Mississippi's medical cannabis program. Reeves argued that this amendment shifted the bill's intent away from helping Mississippians and instead opened the door to a form of cannabis tourism that conflicted with the program's original mission.

The governor's objections drew immediate criticism from the bills' sponsors and medical cannabis advocates, who pointed out that the out-of-state provision was a relatively minor component of legislation primarily designed to help critically ill Mississippi residents. Patient advocates noted that neighboring states without medical cannabis programs leave their residents with no options, and that compassionate access should not stop at state lines.

Veto-Proof Majorities and the Push for Override

What makes this situation particularly noteworthy is that both bills passed the Mississippi legislature with overwhelming bipartisan support. Both HB 1152 and HB 895 cleared the House and Senate with margins that exceeded the two-thirds threshold required for a veto override — a rarity in Mississippi politics and a clear signal that lawmakers across party lines recognized the need for program expansion.

In the days following the veto, protesters including medical cannabis patients, dispensary owners, cultivators, and advocates converged on the Mississippi Capitol to urge lawmakers to exercise their constitutional authority and override the governor's decision. The demonstrations have drawn national attention to Mississippi's medical cannabis program and the ongoing tension between executive and legislative branches over cannabis policy.

Legislative leaders have signaled that an override vote is under serious consideration, which would mark a historic moment in Mississippi's cannabis policy. If successful, it would be one of the first veto overrides on cannabis legislation in the state's history and would send a powerful message about the bipartisan support medical marijuana enjoys in one of the country's most conservative states.

The Psychedelic Paradox

Adding a layer of irony to the situation, Governor Reeves chose to sign separate legislation supporting research into psychedelic therapies, including psilocybin, ibogaine, and MDMA, for military veterans. The psychedelic research bill was part of a broader national movement supported by senators from both parties, including Sens. Tim Sheehy (R-MT), Tammy Duckworth (D-IL), Ruben Gallego (D-AZ), and John Boozman (R-AR), who filed a companion bill to create a new Department of Veterans Affairs office promoting psychedelic research.

The juxtaposition has not gone unnoticed. Advocates have questioned the logic of supporting research into Schedule I [Quick Definition: The most restrictive federal drug classification, currently including heroin and cannabis] psychedelics while simultaneously blocking expanded access to a substance that Mississippi voters explicitly approved for medical use. The governor's willingness to embrace psychedelic research while restricting cannabis access underscores the increasingly complex and sometimes contradictory landscape of drug policy reform in 2026.

What Comes Next for Mississippi Patients

The coming weeks will be critical for Mississippi's medical cannabis community. If lawmakers proceed with an override vote and succeed, the expanded program could be operational by mid-2026, providing relief to patients who have been waiting years for meaningful access improvements.

Regardless of the override outcome, the episode highlights a growing disconnect between elected officials and their constituents on cannabis policy. Mississippi voters approved medical cannabis by a wide margin, and the legislature has demonstrated clear support for expansion. The governor's veto stands as one of the last remaining barriers, and the political pressure to remove it is intensifying by the day.

For patients currently in the program, the existing framework remains in place. Those with qualifying conditions can continue to access medical cannabis through licensed dispensaries, though the restrictions that HB 895 sought to eliminate — including the THC potency cap and frequent physician visit requirements — will remain in effect for now.

Pull-Quote Suggestions:

"The coming weeks will be critical for Mississippi's medical cannabis community."

"The contradictory decisions have left patients, lawmakers, and industry stakeholders demanding answers and pushing for an unprecedented veto override."

"The governor's objections drew immediate criticism from the bills' sponsors and medical cannabis advocates, who pointed out that the out-of-state provision was a relatively minor component of legislation primarily designed to help critically ill Mississippi residents."

Why It Matters: Mississippi Gov. Tate Reeves vetoed two medical cannabis expansion bills while signing psychedelic research legislation. Lawmakers push for override vote.